Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$779K Buy
3,500
+200
+6% +$36.3K ﹤0.01% 2586
2026
Q1
$507K Sell
3,300
-9,500
-74% -$1.29M ﹤0.01% 2807
2025
Q4
$1.45M Buy
12,800
+3,900
+44% +$474K ﹤0.01% 2035
2025
Q3
$1.18M Buy
8,900
+3,500
+65% +$481K ﹤0.01% 2140
2025
Q2
$769K Sell
5,400
-3,200
-37% -$453K ﹤0.01% 2306
2025
Q1
$1.32M Buy
+8,600
New +$1.35M ﹤0.01% 1626
2024
Q4
Sell
-1,400
Closed -$230K 3126
2024
Q3
$230K Sell
1,400
-2,600
-65% -$384K ﹤0.01% 2458
2024
Q2
$554K Buy
+4,000
New +$551K ﹤0.01% 1759

Other funds holding DVA

Paul Tudor Jones's DVA Position: Q2 2026 in Review

Paul Tudor Jones reduced its DaVita (DVA) stake by 25% in Q2 2026, selling an estimated $3.64M and leaving 59,895 shares worth $13.3M. The position accounts for 0.02% of the portfolio, ranked #680.

Paul Tudor Jones first reported a position in DVA in Q4 2013 and has held it in 24 quarters since. The position peaked at $36.8M in Q4 2025. 627 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • Paul Tudor Jones held 59,895 shares of DaVita worth $13.3M as of Q2 2026.
  • Paul Tudor Jones sold 20,020 DaVita shares in Q2 2026, an estimated $3.64M.
  • DaVita made up 0.02% of Paul Tudor Jones's portfolio in Q2 2026, its #680 holding.
  • Paul Tudor Jones first reported a position in DaVita in Q4 2013 and has held it in 24 quarters since.
  • Paul Tudor Jones's DaVita position peaked at $36.8M in Q4 2025.
  • 627 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.